3.1: Risk Identification
Enhance the ability to quickly identify risks associated with FDA-regulated products. Other Information:
The FDA will supplement the current passive reporting system by developing new ways to identify safety problems with medical
products, dietary supplements and foods. This will speed up the process of recognizing safety problems and allow for prevention
of similar adverse events. Partnerships with health care providers and the CDC will allow the FDA to link to medical records
and other public health monitoring systems to identify adverse events quickly. This means, for instance, if a drug were causing
problems in a few patients' kidneys it would be detected early and managed before other patients risk injury.
Indicator(s):
|
